GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » ROA %

Instadose Pharma (Instadose Pharma) ROA % : -10.03% (As of Feb. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Instadose Pharma's annualized Net Income for the quarter that ended in Feb. 2022 was $-3.62 Mil. Instadose Pharma's average Total Assets over the quarter that ended in Feb. 2022 was $36.14 Mil. Therefore, Instadose Pharma's annualized ROA % for the quarter that ended in Feb. 2022 was -10.03%.

The historical rank and industry rank for Instadose Pharma's ROA % or its related term are showing as below:

INSD's ROA % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.7
* Ranked among companies with meaningful ROA % only.

Instadose Pharma ROA % Historical Data

The historical data trend for Instadose Pharma's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma ROA % Chart

Instadose Pharma Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21
ROA %
Get a 7-Day Free Trial -640.00 -2,300.00 - - -

Instadose Pharma Quarterly Data
May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -10.03

Competitive Comparison of Instadose Pharma's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instadose Pharma's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's ROA % distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's ROA % falls into.



Instadose Pharma ROA % Calculation

Instadose Pharma's annualized ROA % for the fiscal year that ended in Nov. 2021 is calculated as:

ROA %=Net Income (A: Nov. 2021 )/( (Total Assets (A: Nov. 2020 )+Total Assets (A: Nov. 2021 ))/ count )
=-0.469/( (0+0)/ 1 )
=-0.469/0
=N/A %

Instadose Pharma's annualized ROA % for the quarter that ended in Feb. 2022 is calculated as:

ROA %=Net Income (Q: Feb. 2022 )/( (Total Assets (Q: Nov. 2021 )+Total Assets (Q: Feb. 2022 ))/ count )
=-3.624/( (0+36.142)/ 1 )
=-3.624/36.142
=-10.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Feb. 2022) net income data. ROA % is displayed in the 30-year financial page.


Instadose Pharma  (OTCPK:INSD) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Feb. 2022 )
=Net Income/Total Assets
=-3.624/36.142
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-3.624 / 0)*(0 / 36.142)
=Net Margin %*Asset Turnover
=N/A %*0
=-10.03 %

Note: The Net Income data used here is four times the quarterly (Feb. 2022) net income data. The Revenue data used here is four times the quarterly (Feb. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Instadose Pharma ROA % Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Instadose Pharma (Instadose Pharma) Business Description

Traded in Other Exchanges
N/A
Address
5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6
Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.

Instadose Pharma (Instadose Pharma) Headlines

From GuruFocus